BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 28400030)

  • 1. Detection of Residual Pulmonary Vascular Obstruction by Ventilation-Perfusion Lung Scan Late After a First Pulmonary Embolism.
    Chopard R; Genet B; Ecarnot F; Chatot M; Napporn G; Hyvert A; Didier-Petit K; Schiele F; Meneveau N
    Am J Cardiol; 2017 Jun; 119(11):1883-1889. PubMed ID: 28400030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term prognostic value of residual pulmonary vascular obstruction at discharge in patients with intermediate- to high-risk pulmonary embolism.
    Meneveau N; Ider O; Seronde MF; Chopard R; Davani S; Bernard Y; Schiele F
    Eur Heart J; 2013 Mar; 34(9):693-701. PubMed ID: 23103660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Residual pulmonary vascular obstruction and recurrence after acute pulmonary embolism. A single center cohort study.
    Planquette B; Ferré A; Peron J; Vial-Dupuy A; Pastre J; Mourin G; Emmerich J; Collignon MA; Meyer G; Sanchez O
    Thromb Res; 2016 Dec; 148():70-75. PubMed ID: 27815969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of residual pulmonary vascular obstruction after pulmonary embolism: Results from a prospective cohort study.
    Picart G; Robin P; Tromeur C; Orione C; Raj L; Ferrière N; Le Mao R; Le Roux PY; Le Floch PY; Lemarié CA; Nonent M; Leroyer C; Guegan M; Lacut K; Salaün PY; Couturaud F
    Thromb Res; 2020 Oct; 194():1-7. PubMed ID: 32554255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What's next after the clot? Residual pulmonary vascular obstruction after pulmonary embolism: From imaging finding to clinical consequences.
    Bonnefoy PB; Margelidon-Cozzolino V; Catella-Chatron J; Ayoub E; Guichard JB; Murgier M; Bertoletti L
    Thromb Res; 2019 Dec; 184():67-76. PubMed ID: 31710860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Residual pulmonary vascular obstruction and recurrence after acute pulmonary embolism: protocol for a systematic review and meta-analysis of individual participant data.
    Robin P; Eddy M; Sikora L; Le Roux PY; Carrier M; Couturaud F; Planquette B; Pesavento R; Rodger M; Salaun PY; Le Gal G
    BMJ Open; 2018 Nov; 8(11):e023939. PubMed ID: 30498046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Residual pulmonary vascular obstruction and recurrence after acute pulmonary embolism: a systematic review and meta-analysis of individual participant data.
    Robin P; Le Pennec R; Eddy M; Sikora L; Le Roux PY; Carrier M; Couturaud F; Tromeur C; Planquette B; Sanchez O; Pesavento R; Filippi L; Rodger MA; Kovacs MJ; Mallick R; Salaun PY; Le Gal G
    J Thromb Haemost; 2023 Jun; 21(6):1519-1528.e2. PubMed ID: 36740040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinogen and the prediction of residual obstruction manifested after pulmonary embolism treatment.
    Planquette B; Sanchez O; Marsh JJ; Chiles PG; Emmerich J; Le Gal G; Meyer G; Wolfson T; Gamst AC; Moore RE; Gugiu GB; Morris TA
    Eur Respir J; 2018 Nov; 52(5):. PubMed ID: 30337447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of residual pulmonary vascular obstruction after anticoagulation monotherapy in patients with intermediate-risk pulmonary embolism.
    Chang Y; Moon JY; Park JH; Choi S; Lee HP; Sim JK; Lee YS
    J Thorac Dis; 2021 Jul; 13(7):4217-4227. PubMed ID: 34422350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors and treatment interventions associated with incomplete thrombus resolution and pulmonary hypertension after pulmonary embolism.
    Fang A; Mayorga-Carlin M; Han P; Cassady S; John T; LaRocco A; Etezadi V; Jones K; Nagarsheth K; Toursavadkohi S; Jeudy J; Anderson D; Griffith B; Sorkin JD; Sarkar R; Lal BK; Cires-Drouet RS
    J Vasc Surg Venous Lymphat Disord; 2024 Jan; 12(1):101665. PubMed ID: 37595746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced fibrin clot permeability on admission and elevated E-selectin at 3 months as novel risk factors of residual pulmonary vascular obstruction in patients with acute pulmonary embolism.
    Stępień K; Ząbczyk M; Kopytek M; Natorska J; Zalewski J; Undas A
    J Thromb Thrombolysis; 2024 Feb; 57(2):248-259. PubMed ID: 37932588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thromboembolic resolution assessed by CT pulmonary angiography after treatment for acute pulmonary embolism.
    den Exter PL; van Es J; Kroft LJ; Erkens PM; Douma RA; Mos IC; Jonkers G; Hovens MM; Durian MF; ten Cate H; Beenen LF; Kamphuisen PW; Huisman MV;
    Thromb Haemost; 2015 Jul; 114(1):26-34. PubMed ID: 26017397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The correlation between elevated cardiac troponin I and pulmonary artery obstruction index in ED patients with pulmonary embolism.
    Shokoohi H; Shesser R; Smith JP; Hill MC; Hirsch R
    Am J Emerg Med; 2009 May; 27(4):449-53. PubMed ID: 19555616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Residual pulmonary embolism as a predictor for recurrence after a first unprovoked episode: Results from the REVERSE cohort study.
    Wan T; Rodger M; Zeng W; Robin P; Righini M; Kovacs MJ; Tan M; Carrier M; Kahn SR; Wells PS; Anderson DR; Chagnon I; Solymoss S; Crowther M; White RH; Vickars L; Bazarjani S; Le Gal G
    Thromb Res; 2018 Feb; 162():104-109. PubMed ID: 29224973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of residual pulmonary obstruction on the long-term outcome of patients with pulmonary embolism.
    Pesavento R; Filippi L; Palla A; Visonà A; Bova C; Marzolo M; Porro F; Villalta S; Ciammaichella M; Bucherini E; Nante G; Battistelli S; Muiesan ML; Beltramello G; Prisco D; Casazza F; Ageno W; Palareti G; Quintavalla R; Monti S; Mumoli N; Zanatta N; Cappelli R; Cattaneo M; Moretti V; Corà F; Bazzan M; Ghirarduzzi A; Frigo AC; Miniati M; Prandoni P;
    Eur Respir J; 2017 May; 49(5):. PubMed ID: 28546279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of recurrence in patients with pulmonary embolism: predictive role of D-dimer and of residual perfusion defects on lung scintigraphy.
    Poli D; Cenci C; Antonucci E; Grifoni E; Arcangeli C; Prisco D; Abbate R; Miniati M
    Thromb Haemost; 2013 Feb; 109(2):181-6. PubMed ID: 23196319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient outcomes after acute pulmonary embolism. A pooled survival analysis of different adverse events.
    Klok FA; Zondag W; van Kralingen KW; van Dijk AP; Tamsma JT; Heyning FH; Vliegen HW; Huisman MV
    Am J Respir Crit Care Med; 2010 Mar; 181(5):501-6. PubMed ID: 19965808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Impact of Pulmonary Vascular Obstruction on the Risk of Recurrence of Pulmonary Embolism: A French Prospective Cohort.
    Orione C; Tromeur C; Le Mao R; Le Floch PY; Robin P; Hoffmann C; Bressollette L; Nonent M; Le Roux PY; Salaun PY; Guegan M; Poulhazan E; Lacut K; Leroyer C; Lemarié CA; Couturaud F
    Thromb Haemost; 2021 Jul; 121(7):955-963. PubMed ID: 33469906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of pulmonary artery obstruction index with elevated heart-type fatty acid binding protein and short-term mortality in patients with pulmonary embolism at intermediate risk.
    Gul EE; Can I; Guler I; Yesildag A; Abdulhalikov T; Kayrak M; Ozdemir K; Gok H
    Diagn Interv Radiol; 2012; 18(6):531-6. PubMed ID: 22991097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia as an independent predictor of adverse outcomes in pulmonary embolism.
    Subramanian M; Ramadurai S; Arthur P; Gopalan S
    Asian Cardiovasc Thorac Ann; 2018 Jan; 26(1):38-43. PubMed ID: 29260572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.